



Aim: To compare the immunohistochemical expression of survivin and further evaluate its 
prognostic significance among three grades (well differentiated, moderately differentiated, and 
poorly differentiated) of oral squamous cell carcinoma.  
Materials and Methods: The study material consisted of 60 formalin fixed paraffin embedded 
tissue samples: 15 cases each of well differentiated, moderately differentiated and poorly 
differentiated oral squamous cell carcinoma and normal oral mucosal epithelium as control. 
Survivin expression was analyzed immunohistochemically and data analysis was accomplished 
using SPSS version 22.0. Fisher’s chi square test was opted to compare the variance in 
distribution, intensity of staining, percentage of immunopositivity and assess pairwise 
comparison between the groups (WDSCC & MDSCC, MDSCC & PDSCC and WDSCC & 
PDSCC). Analysis of Variance (ANOVA) technique was used to compare the immunoreactivity 
score of survivin within the four groups. A 'p' value less than 0.05 denotes significant 
relationship.  
Results: Survivin was expressed in all grades of oral squamous cell carcinoma, but absent in 
normal oral tissue samples. There was a statistically significant difference among the three 
grades of oral squamous cell carcinoma in relation to survivin immunopositivity and 
immunoreactivity (p<0.01). High immunopositivity and strong staining intensity for survivin, 
predominantly in nuclear areas were observed in poorly differentiated oral squamous cell 
carcinoma whereas moderate immunopositivity and staining intensity were observed in well and 
moderately differentiated oral squamous cell carcinoma. 
Conclusion: Higher survivin expression and its nuclear localization appeared to correlate with 
higher grade of malignancy. Survivin was highly expressed in poorly differentiated oral 
squamous cell carcinoma compared to well and moderately differentiated oral squamous cell 
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carcinoma suggesting unfavourable prognosis. Based on the present study, it was concluded that 
survivin may be used as an important diagnostic and prognostic marker for aggressive form of 
oral squamous cell carcinoma. To further validate survivin as a prognostic marker, a large scale 
study with greater sample size along with clinical follow-up data is needed. Due to its selective 
expression in tumor cells and absence in normal tissues, it may be used as a therapeutic target for 
oral cancer.  
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